At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,765 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Key inclusion· 5
- ✓Age ≥18 years
- ✓Baseline cancer pain adequately controlled with opioids
- ✓Presence of breakthrough pain episodes associated with cancer pain
- ✓Meets diagnostic criteria for breakthrough cancer pain (Portenoy's criteria and Davies algorithm)
Key exclusion· 2
- ✕Severe mental illness
- ✕Any medical condition or situation complicating data collection as determined by investigator
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain
In Brief
An observational study evaluating No Intervention for Breakthrough Cancer Pain. Completed, enrolled 3,765 participants across 36 sites.
Detailed Summary
The purpose of this study is to determine the prevalence of breakthrough cancer pain and characterize breakthrough cancer pain in an unselected, representative cohort of cancer outpatients with or without pain who attend consultations.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreakthrough Cancer Pain
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartNov 2016
Primary CompletionApr 2018
Study CompletionJul 2018
TodayJul 2026
First PostedSep 14, 2016
Enrollment StartNov 14, 2016
Primary CompletionApr 4, 2018
Study CompletionJul 16, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.8 years ago
Interventions
No Interventionother